Evolent Health, Inc. - Class A Shares (EVH)

$29.64

-0.52

(-1.72%)▲

Market is closed - opens 7 PM, 18 Apr 2024

Insights on Evolent Health, Inc. - Class A Shares

  • Increasing Revenue

    Revenue is up for the last 12 quarters, 215.07M → 556.05M (in $), with an average increase of 8.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -25.32M → -33.41M (in $), with an average decrease of 31.9% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 36.6% return, outperforming this stock by 47.8%

Performance

  • $29.35
    $30.25
    $29.64
    downward going graph

    0.98%

    Downside

    Day's Volatility :2.96%

    Upside

    2.0%

    downward going graph
  • $23.33
    $36.70
    $29.64
    downward going graph

    21.29%

    Downside

    52 Weeks Volatility :36.43%

    Upside

    19.24%

    downward going graph

Returns

PeriodEvolent Health, Inc. - Class A SharesSector (Health Care)Index (Russel 2000)
3 Months
-1.28%
-0.5%
0.0%
6 Months
6.65%
5.9%
0.0%
1 Year
-11.16%
3.1%
-1.9%
3 Years
52.63%
14.2%
-21.8%

Highlights

Market Capitalization
3.5B
Book Value
$9.38
Earnings Per Share (EPS)
-1.28
PEG Ratio
-1.37
Wall Street Target Price
44.67
Profit Margin
-5.76%
Operating Margin TTM
1.23%
Return On Assets TTM
0.86%
Return On Equity TTM
-10.74%
Revenue TTM
2.0B
Revenue Per Share TTM
17.65
Quarterly Revenue Growth YOY
45.4%
Gross Profit TTM
316.6M
EBITDA
127.5M
Diluted Eps TTM
-1.28
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
1.16
EPS Estimate Next Year
1.63
EPS Estimate Current Quarter
0.15
EPS Estimate Next Quarter
0.21

Analyst Recommendation

Buy
    86%Buy
    13%Hold
    0
    0%Sell
Based on 15 Wall street analysts offering stock ratings for Evolent Health, Inc. - Class A Shares(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
12
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 50.71%

Current $29.64
Target $44.67

Company Financials

FY18Y/Y Change
Revenue
627.1M
↑ 44.17%
Net Income
-52.7M
↓ 13.2%
Net Profit Margin
-8.4%
↑ 5.55%
FY19Y/Y Change
Revenue
846.4M
↑ 34.98%
Net Income
-305.6M
↑ 480.31%
Net Profit Margin
-36.1%
↓ 27.7%
FY20Y/Y Change
Revenue
1.0B
↑ 20.8%
Net Income
-334.2M
↑ 9.38%
Net Profit Margin
-32.69%
↑ 3.41%
FY21Y/Y Change
Revenue
908.0M
↓ 11.2%
Net Income
-30.3M
↓ 90.94%
Net Profit Margin
-3.34%
↑ 29.35%
FY22Y/Y Change
Revenue
1.4B
↑ 48.91%
Net Income
-18.7M
↓ 38.25%
Net Profit Margin
-1.38%
↑ 1.96%
FY23Y/Y Change
Revenue
2.0B
↑ 45.26%
Net Income
-113.0M
↑ 504.46%
Net Profit Margin
-5.76%
↓ 4.38%
Q3 FY22Q/Q Change
Revenue
352.6M
↑ 10.2%
Net Income
2.1M
↓ 151.47%
Net Profit Margin
0.6%
↑ 1.89%
Q4 FY22Q/Q Change
Revenue
382.4M
↑ 8.47%
Net Income
-11.3M
↓ 634.57%
Net Profit Margin
-2.97%
↓ 3.57%
Q1 FY23Q/Q Change
Revenue
427.7M
↑ 11.83%
Net Income
-20.0M
↑ 76.07%
Net Profit Margin
-4.67%
↓ 1.7%
Q2 FY23Q/Q Change
Revenue
469.1M
↑ 9.69%
Net Income
-34.3M
↑ 71.77%
Net Profit Margin
-7.32%
↓ 2.65%
Q3 FY23Q/Q Change
Revenue
511.0M
↑ 8.93%
Net Income
-25.3M
↓ 26.22%
Net Profit Margin
-4.96%
↑ 2.36%
Q4 FY23Q/Q Change
Revenue
556.1M
↑ 8.81%
Net Income
-33.4M
↑ 31.93%
Net Profit Margin
-6.01%
↓ 1.05%
FY18Y/Y Change
Total Assets
1.7B
↑ 31.2%
Total Liabilities
532.9M
↑ 100.05%
FY19Y/Y Change
Total Assets
1.5B
↓ 13.02%
Total Liabilities
569.0M
↑ 6.76%
FY20Y/Y Change
Total Assets
1.4B
↓ 8.53%
Total Liabilities
750.6M
↑ 31.92%
FY21Y/Y Change
Total Assets
1.4B
↑ 3.6%
Total Liabilities
725.8M
↓ 3.3%
FY22Y/Y Change
Total Assets
1.8B
↑ 28.03%
Total Liabilities
957.9M
↑ 31.97%
FY23Y/Y Change
Total Assets
2.7B
↑ 47.49%
Total Liabilities
1.6B
↑ 68.35%
Q3 FY22Q/Q Change
Total Assets
1.8B
↑ 34.92%
Total Liabilities
903.0M
↑ 30.72%
Q4 FY22Q/Q Change
Total Assets
1.8B
↑ 3.3%
Total Liabilities
957.9M
↑ 6.07%
Q1 FY23Q/Q Change
Total Assets
2.6B
↑ 42.49%
Total Liabilities
1.5B
↑ 53.23%
Q2 FY23Q/Q Change
Total Assets
2.6B
↑ 2.22%
Total Liabilities
1.6B
↑ 5.85%
Q3 FY23Q/Q Change
Total Assets
2.7B
↑ 0.86%
Total Liabilities
1.6B
↑ 1.28%
Q4 FY23Q/Q Change
Total Assets
2.7B
↑ 0.4%
Total Liabilities
1.6B
↑ 2.48%
FY18Y/Y Change
Operating Cash Flow
-20.7M
↓ 26.14%
Investing Cash Flow
-160.4M
↑ 1207.58%
Financing Cash Flow
274.0M
↑ 65.52%
FY19Y/Y Change
Operating Cash Flow
-42.6M
↑ 106.5%
Investing Cash Flow
-181.6M
↑ 13.26%
Financing Cash Flow
-35.5M
↓ 112.97%
FY20Y/Y Change
Operating Cash Flow
-16.2M
↓ 61.95%
Investing Cash Flow
261.1M
↓ 243.74%
Financing Cash Flow
-11.9M
↓ 66.63%
FY21Y/Y Change
Operating Cash Flow
38.7M
↓ 338.81%
Investing Cash Flow
-15.8M
↓ 106.05%
Financing Cash Flow
-29.5M
↑ 149.1%
FY22Y/Y Change
Operating Cash Flow
-11.6M
↓ 129.82%
Investing Cash Flow
-259.1M
↑ 1541.42%
Financing Cash Flow
131.5M
↓ 545.18%
Q3 FY22Q/Q Change
Operating Cash Flow
-3.5M
↓ 125.4%
Investing Cash Flow
-255.0M
↑ 1451.41%
Financing Cash Flow
173.1M
↑ 736.54%
Q4 FY22Q/Q Change
Operating Cash Flow
35.7M
↓ 1128.67%
Investing Cash Flow
-4.5M
↓ 98.25%
Financing Cash Flow
-10.9M
↓ 106.27%
Q1 FY23Q/Q Change
Operating Cash Flow
-8.0M
↓ 122.34%
Investing Cash Flow
-395.0M
↑ 8764.3%
Financing Cash Flow
379.7M
↓ 3598.52%
Q2 FY23Q/Q Change
Operating Cash Flow
654.0K
↓ 108.2%
Investing Cash Flow
-8.4M
↓ 97.89%
Financing Cash Flow
23.3M
↓ 93.86%
Q3 FY23Q/Q Change
Operating Cash Flow
60.5M
↑ 9153.98%
Investing Cash Flow
-409.5M
↑ 4801.75%
Financing Cash Flow
-37.4M
↓ 260.17%

Technicals Summary

Sell

Neutral

Buy

Evolent Health, Inc. - Class A Shares is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Evolent Health, Inc. - Class A Shares
Evolent Health, Inc. - Class A Shares
-6.25%
6.65%
-11.16%
52.63%
137.48%
Solventum Corp
Solventum Corp
-10.35%
-10.35%
-10.35%
-10.35%
-10.35%
Veeva Systems Inc.
Veeva Systems Inc.
-12.28%
-3.64%
11.92%
-25.89%
55.54%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-5.22%
28.56%
3.82%
41.97%
41.97%
Healthequity Inc
Healthequity Inc
-3.24%
7.03%
36.58%
13.47%
28.25%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Evolent Health, Inc. - Class A Shares
Evolent Health, Inc. - Class A Shares
712.02
NA
-1.37
1.16
-0.11
0.01
NA
9.38
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.42
62.42
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.36
28.36
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
125.36
125.36
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Evolent Health, Inc. - Class A Shares
Evolent Health, Inc. - Class A Shares
Buy
$3.5B
137.48%
712.02
-5.76%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.35%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.5B
55.54%
62.42
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.3B
41.97%
28.36
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
28.25%
125.36
5.57%

Institutional Holdings

  • FMR Inc

    11.32%

  • Vanguard Group Inc

    9.50%

  • BlackRock Inc

    7.40%

  • Wellington Management Company LLP

    7.30%

  • JPMorgan Chase & Co

    5.20%

  • Rock Springs Capital Management LP

    3.48%

Company Information

our company evolent health supports progressive health care systems lead, build and own the path to value-based care. headquartered in arlington, virginia, we are backed by: the advisory board company (nasdaq: abco), university of pittsburgh medical center health plan, and tpg growth. we integrate the people, processes and technology needed to advance value-based care delivery and innovative payment models. our culture we’ve built a team of dedicated individuals who genuinely enjoy working together. our accessible leadership team cultivates an open-door environment. we take smart risks and when we fail, we fail forward. we respect and encourage commitments outside of work. while we don’t all work the same way or the same hours, we are all dedicated to exceptional results. our benefits treadmill desks, healthy snacks and wellness challenges are just part of our resolve to promote a healthy (and fun!) work environment. we recognize and reward our most valuable asset—our team—wi

Organization
Evolent Health, Inc. - Class A Shares
Employees
4700
CEO
Mr. Seth Barrie Blackley
Industry
Miscellaneous Commercial Services

Discover More

FAQs